This inventor holds 11 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of Central Florida Research Foundation Inc.. Active years: 2011-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Orlando, DE (US) (2014)
- Chicago, IL (US) (2015)
- Orlando, FL (US) (2011 - 2016)
- Birmingham, AL (US) (2016)
Company Filing History:
Years Active: 2011-2016
Title: Innovations by Angel Alvarez
Introduction
Angel Alvarez is a prominent inventor based in Orlando, Florida. He has made significant contributions to the field of cell development and differentiation. With a total of 11 patents to his name, Alvarez is recognized for his innovative approaches to enhancing the potency of cells.
Latest Patents
Among his latest patents, Alvarez has developed methods and materials for increasing the potency of cells. These methods involve introducing an expressible dedifferentiating polynucleotide sequence into less developmentally potent cells. This process allows these cells to become more developmentally potent, enabling them to differentiate into their lineage of origin or a different lineage. Another notable patent focuses on biasing cells toward retinal, corneal, or lens development. This method describes how potent and multipotent stem cells can be transfected with a nucleic acid sequence to achieve desired end-stage cell characteristics.
Career Highlights
Alvarez works at the University of Central Florida Research Foundation, Inc., where he continues to push the boundaries of cell research. His work has garnered attention for its potential applications in regenerative medicine and therapeutic interventions.
Collaborations
Alvarez collaborates with esteemed colleagues, including Kiminobu Sugaya and Amelia Marutle, who contribute to his research endeavors.
Conclusion
Angel Alvarez's innovative work in cell development showcases his commitment to advancing scientific knowledge and improving medical outcomes. His contributions are paving the way for future breakthroughs in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
